Inc. (NASDAQ: EPZM), a clinical stage biopharmaceutical company
creating innovative personalized therapeutics for patients with
genetically defined cancers, announced today that it will host a live
audio webcast of its discussion of the Company’s clinical programs and
pipeline at the ASH annual meeting on Monday, December 8, 2014, at 12:30
p.m. PT (3:30 p.m. ET).
The webcast will be available in the Events and Presentations section
under the Investor Relations section of the Company's website at www.epizyme.com ,
and an archived replay of the webcast will be available for 30 days
after the presentation.
for Epizyme to Webcast Company Presentation at American Society of Hematology (ASH) Annual Meeting on December 8, 2014 investment picks